NCT06267183View on ClinicalTrials.gov

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 12, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 30, 2025

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

SV001

SV001 ： single-dose

DRUG

Placebo

Placebo ： single-dose

Trial Locations (1)

Unknown

RECRUITING

Shanghai Xuhui District Central Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Synvida Biotechnology Co.,Ltd.

INDUSTRY